#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital growth hormone deficiency Mantle cell lymphoma stage IV Noonan syndrome Hypochondroplasia Isodicentric chromosome 15 syndrome ROHHAD syndrome Glomerulonephritis membranous B-cell small lymphocytic lymphoma recurrent Sickle cell disease Heart disease congenital Frostbite Cerebral arteriovenous malformation haemorrhagic Metachromatic leukodystrophy Mantle cell lymphoma recurrent Pulmonary tuberculosis More trials…

    Learn about Rare Diseases

    Vascular malformation – Diagnostics Angelman’s syndrome – Treatment VEXAS syndrome – Basic Information Mantle cell lymphoma refractory – Trials in Disease Mantle cell lymphoma refractory – Basic Information Primary biliary cholangitis – Basic Information Choroid melanoma – Treatment Lymphatic malformation – Life with Disease Haemophilia A with anti factor VIII – Treatment Prader-Willi syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oxytocin Synthetic Ketoprofen Lysine L-Tryptophan Clomifene Citrate Dl-Alpha-Tocopherol Gentamicin Sulfate Levofloxacin USNOFLAST Sunvozertinib Fianlimab GSK5460025A Lenzumestrocel GSK3862995B RO7268489 AMG 732 Baxdrostat Meropenem Trihydrate BROLUCIZUMAB Citric Acid Toldc More therapies…

    Learn about Your Condition

    Bronchiolitis Polymyositis Adenocarcinoma pancreas Lower limb fracture Infantile spasms Congenital ureteric anomaly Genital herpes simplex Basal cell carcinoma Vulvovaginal pain Angelman's syndrome Menopausal symptoms Epileptic encephalopathy Neonatal asphyxia Lumbosacral radiculopathy Oesophageal achalasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Luxembourg

  • Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

    Not recruiting

    2 1
    Investigated Diseases:
    • Lung disorder
    Investigated Drugs:
    • Bemcentinib
    Belgium Czechia France Greece Ireland Italy +4

  • Study on the Safety and Effectiveness of Magrolimab with Bevacizumab and Drug Combination for Patients with Advanced Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Magrolimab
    • Calcium Levofolinate
    • Bevacizumab
    Belgium France Germany Italy Spain

  • Study of Vobramitamab Duocarmazine and Prednisone for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Vobramitamab Duocarmazine
    • Prednisone
    Belgium Czechia France Germany Italy Poland +1

  • Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Resected Colon Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Placebo
    • Acetylsalicylic Acid
    Belgium

  • Study on Treatment for Recurrent Platinum-Sensitive Ovarian, Peritoneal, or Fallopian Tube Cancer Using Carboplatin and Mirvetuximab Soravtansine in Eligible Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    • Fallopian tube cancer
    Investigated Drugs:
    • Prednisolone Acetate
    • Mirvetuximab Soravtansine
    • Carboplatin
    Belgium Ireland Spain

  • Study on Trilaciclib and Topotecan for Patients with Extensive Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Trilaciclib Dihydrochloride Dihydrate
    • Glucose Monohydrate
    • Topotecan
    Austria Belgium Bulgaria Germany Greece Hungary +2
Previous Page
1 … 3 4 5 6
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Fluorouracil Folinic Acid Docetaxel Carboplatin Paclitaxel Capecitabine Oxaliplatin Sodium Chloride Pembrolizumab Prednisolone Acetate Fulvestrant Durvalumab Acetylsalicylic Acid Nivolumab Bevacizumab Prednisone Datopotamab Deruxtecan Olaparib Dexamethasone Prasinezumab Paclitaxel Albumin-Bound Sodium Hydrogen Carbonate Pheur Mps-215 Igg4 Tetravalent Bispecific Antibody-Like Protein Against Pd-1 And Ctla4 Clopidogrel Topotecan Trastuzumab Df1001 Mps-216 Saruparib Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute coronary syndrome Adenocarcinoma gastric Bladder transitional cell carcinoma Breast cancer Breast cancer metastatic Breast cancer stage IV Cervix carcinoma recurrent Chronic coronary syndrome Colon cancer stage II Colon cancer stage III Colorectal cancer metastatic Ductal adenocarcinoma of pancreas Embolism Endometrial cancer Endometrial cancer recurrent Fallopian tube cancer Gastric cancer Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-refractory prostate cancer Lung disorder Malignant peritoneal neoplasm Neoplasm Non-small cell lung cancer Oesophageal adenocarcinoma Oesophageal carcinoma Ovarian cancer Ovarian cancer recurrent Ovarian epithelial cancer Parkinson's disease Prostate cancer Radius fracture Rectal cancer stage II Rectal cancer stage III Small cell lung cancer extensive stage

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!